EUVIMEDOpdag EUVIMED
Crossref

Antimicrobial and Potent Anti‐Biofilm Properties of Rationally Designed α ‐Helix Antimicrobial Peptides

Motasim Ismael iD, Khayeli Juliah, Madivoli Edwin iD

Journal of Peptide Science · 2025

DOI: 10.1002/psc.70027 ↗

At a glance

Journal article in Journal of Peptide Science, 2025. Written by Motasim Ismael and 2 co-authors. Institution: Department of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences Technology and Innovation (PAUSTI), Nairobi, K…. Major MEDLINE topics: Biofilms, Staphylococcus aureus, Anti-Bacterial Agents, Antimicrobial Peptides. Cited 3 times so far (Crossref); 50 references. Funded by: African Union.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The antimicrobial resistance (AMR) crisis represents a significant global threat. Unlike traditional antibiotics, antimicrobial peptides offer a promising pathway because of their primary mechanisms. This study aimed to evaluate and rationally design novel AMPs based on tobacco nectar's AMP (Pep 6) to combat antibiotic resistance issues. Substitution and truncation of some amino acids were applied. Four peptides, KF19, KF16, LK16, and LR16, were designed with enhanced net charge hydrophobicity. They were evaluated for their in vitro antibacterial activity. However, only promising AMPs were further evaluated for their hemolytic activity, time‐killing kinetics, mode of action, and anti‐biofilm properties. The results showed that only KF19 and LR16 have potent activity against Staphylococcus aureus ATCC25923 and resistant isolates with MIC values from 7.81 to 15.62 μg/mL. Hemolysis ratios were 2.38% and 2.24% at 125 μg/mL for KF19 and LR16, respectively. Both peptides were able to kill S. aureus ATCC25923 within 2 h. SEM results showed their ability to target the cell membrane. Both peptides destroyed the S. aureus biofilms significantly at 62.5 and 125 μg/mL (** p < 0.01, *** p < 0.001, **** p < 0.0001). This study supported rational design in developing new antibacterial agents and demonstrated the therapeutic potency of novel peptides that could solve the resistance issues.

Subjects

MeSH terms (MEDLINE)

BiofilmsStaphylococcus aureusAnti-Bacterial AgentsAntimicrobial PeptidesDrug DesignMicrobial Sensitivity TestsHemolysisProtein Conformation, alpha-HelicalStructure-Activity Relationship

Author keywords

AMPsAMRMICSEManti‐biofilmhemolysisrational design

Substances

Anti-Bacterial AgentsAntimicrobial Peptides

Authors and institutions

  • Department of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences Technology and Innovation (PAUSTI), Nairobi, Kenya.
  • Department of Zoology, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
  • Department of Chemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
  • Department of Physics and Biophysics, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.

ORCID profiles: Motasim Ismael, Madivoli Edwin

Funding

  • African Union

Cite

APA

Ismael, M., Juliah, K., & Edwin, M. (2025). Antimicrobial and Potent Anti‐Biofilm Properties of Rationally Designed α ‐Helix Antimicrobial Peptides. Journal of Peptide Science. https://doi.org/10.1002/psc.70027

Vancouver

Ismael M, Juliah K, Edwin M. Antimicrobial and Potent Anti‐Biofilm Properties of Rationally Designed α ‐Helix Antimicrobial Peptides. Journal of Peptide Science. 2025. doi:10.1002/psc.70027

BibTeX
@article{Ismael2025,
  author = {Ismael, Motasim and Juliah, Khayeli and Edwin, Madivoli},
  title = {Antimicrobial and Potent Anti‐Biofilm Properties of Rationally Designed α ‐Helix Antimicrobial Peptides},
  journal = {Journal of Peptide Science},
  year = {2025},
  doi = {10.1002/psc.70027}
}
Start for free →